×

1. Lee, I.S., et al., Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer. Gastric Cancer, 2021.
2. Lee, I.S., et al., Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer. Clin Cancer Res, 2021.
3. Ko, C.S., et al., Overlap method versus functional method for esophagojejunal reconstruction using totally laparoscopic total gastrectomy. Surg Endosc, 2021. 35(1): p. 130-138.
4. Kim, K.W., et al., Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study. BMC Cancer, 2021. 21(1): p. 157.
5. Shin, E.J., et al., Early Surgical and Long-term Oncological Outcomes of Totally Laparoscopic Near-total Gastrectomy in >150 Cases. Surg Laparosc Endosc Percutan Tech, 2020. 30(6): p. 529-533.
6. Kim, B.S., et al., Association between the MUC1 rs4072037 Polymorphism and Risk of Gastric Cancer and Clinical Outcomes. J Gastric Cancer, 2020. 20(2): p. 127-138.
7. Kim, A., et al., Optimal proximal resection margin distance for gastrectomy in advanced gastric cancer. World J Gastroenterol, 2020. 26(18): p. 2232-2246.
8. Jeong, G.S., et al., Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers. J Gastric Cancer, 2020. 20(3): p. 233-244.
9. Choi, Y.K., et al., Comparison Between Redo Endoscopic Treatment and Surgery in Patients with Locally Recurrent Gastric Neoplasms. J Gastrointest Surg, 2020. 24(7): p. 1489-1498.
10. Choi, N.Y., et al., Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach. Am Surg, 2020: p. 3134820950000.
11. Choi, M., et al., Comparative outcomes between totally laparoscopic total gastrectomy with the modified overlap method for early gastric cancer and advanced gastric cancer: review of 149 consecutive cases. Wideochir Inne Tech Maloinwazyjne, 2020. 15(3): p. 437-445.
12. Alshehri, A., H.S. Kim, and B.S. Kim, Laparoscopic management of gastric remnant ischemia after laparoscopic distal gastrectomy with Billroth-I anastomosis-A case report. Int J Surg Case Rep, 2020. 66: p. 265-269.
13. Mun, D.G., et al., Proteogenomic Characterization of Human Early-Onset Gastric Cancer. Cancer Cell, 2019. 35(1): p. 111-124.e10.
14. Lee, K., et al., Impact of remnant stomach volume and anastomosis on nutrition and body composition in gastric cancer patients. Surg Oncol, 2019. 31: p. 75-82.
15. Kim, J.H., et al., Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience. Cancer Med, 2019. 8(3): p. 1034-1043.
16. Kim, H.S., et al., Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma. Sci Rep, 2019. 9(1): p. 3414.
17. Kim, H.S., et al., Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncol Lett, 2019. 18(3): p. 3031-3038.
18. Gong, C.S., et al., Diaphragmatic Hernia After Totally Laparoscopic Total Gastrectomy for Gastric Cancer. Surg Laparosc Endosc Percutan Tech, 2019. 29(3): p. 194-199.
19. Choi, B.M., et al., Effects of depth of neuromuscular block on postoperative pain during laparoscopic gastrectomy: A randomised controlled trial. Eur J Anaesthesiol, 2019. 36(11): p. 863-870.
20. Lee, S., et al., Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis. Gastric Cancer, 2018. 21(3): p. 490-499.
21. Lee, I.S., et al., Prognostic impact of extranodal extension in stage 1B gastric carcinomas. Surg Oncol, 2018. 27(2): p. 299-305.
22. Kim, J.H., et al., Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis. Cancer Res Treat, 2018. 50(2): p. 518-529.
23. Kang, M.H., et al., Correction: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1. Oncotarget, 2018. 9(98): p. 37268.
24. Hong, H.N., et al., Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner. J Cancer Res Clin Oncol, 2018. 144(9): p. 1649-1663.
25. Gong, E.J., et al., Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology. PLoS One, 2018. 13(4): p. e0195264.
26. Eom, S.Y., et al., Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res, 2018. 32(4): p. 257-263.
27. Cho, C.J., et al., Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer. Dig Dis Sci, 2018. 63(7): p. 1835-1850.
28. Yoon, S., et al., Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer. Gastric Cancer, 2017. 20(1): p. 182-189.
29. Suh, D.D., et al., Differences in the prognosis of early gastric cancer according to sex and age. Therap Adv Gastroenterol, 2017. 10(2): p. 219-229.
30. Lim, H., et al., Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer, 2017. 20(5): p. 793-801.
31. Lee, T.G., et al., Totally laparoscopic total gastrectomy using the overlap method; early outcomes of 50 consecutive cases. Surg Endosc, 2017. 31(8): p. 3186-3190.
32. Lee, I.S., et al., Applicability of endoscopic submucosal dissection for undifferentiated early gastric cancer: Mixed histology of poorly differentiated adenocarcinoma and signet ring cell carcinoma is a worse predictive factor of nodal metastasis. Surg Oncol, 2017. 26(1): p. 8-12.
33. Lee, I.S., et al., Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol, 2017. 15(1): p. 28.
34. Kim, H.S., et al., Can further gastrectomy be avoided in patients with incomplete endoscopic resection? Surg Endosc, 2017. 31(11): p. 4735-4748.
35. Kim, B.S., et al., Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma. Therap Adv Gastroenterol, 2017. 10(5): p. 407-415.
36. Kang, M.H., et al., Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1. Oncotarget, 2017. 8(58): p. 98887-98897.
37. Jun, S.Y., et al., Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions: Systematic Pathologic Studies of 165 Cases. Am J Surg Pathol, 2017. 41(6): p. 833-848.
38. Jeong, J.H., et al., Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. Gastric Cancer, 2017. 20(1): p. 146-155.
39. Gong, E.J., et al., Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer, 2017. 20(Suppl 1): p. 84-91.
40. Gong, C.S., B.S. Kim, and H.S. Kim, Comparison of totally laparoscopic total gastrectomy using an endoscopic linear stapler with laparoscopic-assisted total gastrectomy using a circular stapler in patients with gastric cancer: A single-center experience. World J Gastroenterol, 2017. 23(48): p. 8553-8561.
41. Choi, K.H., et al., Comparison the sixth and seventh editions of the AJCC staging system for T1 gastric cancer: a long-term follow-up study of 2124 patients. Gastric Cancer, 2017. 20(1): p. 43-48.
42. Cho, S.Y., et al., Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Gastroenterology, 2017. 153(2): p. 536-549.e26.
43. Cho, H., et al., Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis. Gastric Cancer, 2017. 20(6): p. 970-977.
44. Song, M.J., et al., Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study. Gut Liver, 2016. 10(5): p. 731-8.
45. Park, J.H., et al., Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer. Gastric Cancer, 2016. 19(1): p. 226-33.
46. Lee, S., et al., Clinical Outcomes of Postoperative Upper Gastrointestinal Leakage According to Treatment Modality. Dig Dis Sci, 2016. 61(2): p. 523-32.
47. Kim, B.S., et al., Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors. Medicine (Baltimore), 2016. 95(30): p. e3977.
48. Kang, H.J., et al., Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. Ann Surg Oncol, 2016. 23(11): p. 3684-3692.
49. Huh, J., et al., CT gastrography for volumetric measurement of remnant stomach after distal gastrectomy: a feasibility study. Abdom Radiol (NY), 2016. 41(10): p. 1899-905.
50. Hu, N., et al., Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut, 2016. 65(10): p. 1611-8.
51. Gong, C.S., et al., Comparison of survival of surgical resection and conservative treatment in patients with gastric cancer aged 80 years or older: a single-center experience. Ann Surg Treat Res, 2016. 91(5): p. 219-225.
52. Gong, C.S., et al., De Novo Gastric Cancer After Liver Transplantation. Ann Transplant, 2016. 21: p. 386-91.
53. Eom, S.Y., et al., Additive interactions between PRKAA1 polymorphisms and Helicobacter pylori CagA infection associated with gastric cancer risk in Koreans. Cancer Med, 2016. 5(11): p. 3236-3335.
54. Yoo, C., et al., Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence. Ann Surg Oncol, 2015. 22(9): p. 2940-7.
55. Yoo, C., et al., Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib. Ann Surg Oncol, 2015. 22 Suppl 3: p. S362-9.
56. Lim, H., et al., Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus. Clin Gastroenterol Hepatol, 2015. 13(10): p. 1738-1744.e2.
57. Kim, H.S., S.O. Kim, and B.S. Kim, Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer. World J Gastroenterol, 2015. 21(48): p. 13507-17.
58. Kim, B.S., et al., Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme. Medicine (Baltimore), 2015. 94(44): p. e1748.
59. Park, S.J., et al., The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses. Ann Surg Oncol, 2014. 21(13): p. 4211-7.
60. Park, J.Y., et al., Prognostic significance of neuroendocrine components in gastric carcinomas. Eur J Cancer, 2014. 50(16): p. 2802-9.
61. Park, J.H., et al., Metallic stent placement in patients with recurrent malignant obstruction in the surgically altered stomach. Ann Surg Oncol, 2014. 21(6): p. 2036-43.
62. Kim, H.S., et al., Laparoscopic gastrectomy in patients with previous gastrectomy for gastric cancer: a report of 17 cases. Surg Laparosc Endosc Percutan Tech, 2014. 24(2): p. 177-82.
63. Kim, B.S., et al., A simplified technique for tumor localization using preoperative endoscopic clipping and radio-opaque markers during totally laparoscopic gastrectomy. Am Surg, 2014. 80(12): p. 1266-70.
64. Kim, B.S., et al., Appropriate gastrectomy resection margins for early gastric carcinoma. J Surg Oncol, 2014. 109(3): p. 198-201.
65. Kim, B.S., et al., What is the appropriate management for perforated gastric cancer? Am Surg, 2014. 80(5): p. 517-20.
66. Kim, B.S., et al., Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer. Surgery, 2014. 155(6): p. 1030-5.
67. Kang, Y.K., et al., Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101). Cancer Chemother Pharmacol, 2014. 73(1): p. 139-49.
68. Park, I., et al., A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma. Cancer Chemother Pharmacol, 2013. 72(4): p. 815-23.
69. Lee, S., et al., Clinical outcomes of endoscopic and surgical management for postoperative upper gastrointestinal leakage. Surg Endosc, 2013. 27(11): p. 4232-40.
70. Lee, I.S., et al., Pathologic discordance of differentiation between endoscopic biopsy and postoperative specimen in mucosal gastric adenocarcinomas. Ann Surg Oncol, 2013. 20(13): p. 4231-7.
71. Koh, Y.W., et al., Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy. Am J Surg Pathol, 2013. 37(7): p. 1022-9.
72. Kim, M.G., et al., The impact of old age on surgical outcomes of totally laparoscopic gastrectomy for gastric cancer. Surg Endosc, 2013. 27(11): p. 3990-7.
73. Kim, H.S., et al., Analysis of predictive risk factors for postoperative complications of laparoscopy-assisted distal gastrectomy. J Laparoendosc Adv Surg Tech A, 2013. 23(5): p. 425-30.
74. Kim, H.S., et al., Comparison of totally laparoscopic total gastrectomy and laparoscopic-assisted total gastrectomy methods for the surgical treatment of early gastric cancer near the gastroesophageal junction. J Laparoendosc Adv Surg Tech A, 2013. 23(3): p. 204-10.
75. Kim, H.S., et al., Laparoscopic surgery for submucosal tumor near the esophagogastric junction. J Laparoendosc Adv Surg Tech A, 2013. 23(3): p. 225-30.
76. Kim, H.S., et al., Reconstruction of esophagojejunostomies using endoscopic linear staplers in totally laparoscopic total gastrectomy: report of 139 cases in a large-volume center. Surg Laparosc Endosc Percutan Tech, 2013. 23(6): p. e209-16.
77. Kim, H.S., et al., Comparison of totally laparoscopic total gastrectomy and open total gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A, 2013. 23(4): p. 323-31.
78. Kim, H.S., et al., Intracorporeal laparoscopic Roux-en-Y gastrojejunostomy after 95% gastrectomy for early gastric cancer in the upper third of the stomach: a report on 21 cases. J Laparoendosc Adv Surg Tech A, 2013. 23(3): p. 250-7.
79. Kim, B.S., et al., Primary small cell carcinoma of the stomach: clinical outcomes and prognoses. Am Surg, 2013. 79(9): p. e305-7.
80. Jo, J.C., et al., Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer. Asia Pac J Clin Oncol, 2013. 9(4): p. 324-30.
81. An, H.J., et al., The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST. Ann Surg Oncol, 2013. 20(13): p. 4212-8.
82. Park, Y.S., et al., Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? Hum Pathol, 2012. 43(3): p. 413-22.
83. Lee, I.S., et al., Multiple synchronous early gastric cancers: high-risk group and proper management. Surg Oncol, 2012. 21(4): p. 269-73.
84. Lee, I.S., et al., A triangle method: simple suture retraction for the left lobe of the liver during laparoscopic gastric surgery. J Laparoendosc Adv Surg Tech A, 2012. 22(10): p. 989-91.
85. Lee, I.S., et al., Clinical significance of gastric cancer surveillance in renal transplant recipients. World J Surg, 2012. 36(8): p. 1806-10.
86. Lee, I.S., et al., Modified techniques and early outcomes of totally laparoscopic total gastrectomy with side-to-side esophagojejunostomy. J Laparoendosc Adv Surg Tech A, 2012. 22(9): p. 876-80.
87. Kim, M.Y., et al., Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or less. J Clin Gastroenterol, 2012. 46(2): p. 130-7.
88. Kim, K.C., et al., Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. BMC Complement Altern Med, 2012. 12: p. 172.
89. Kim, H.S., et al., Totally laparoscopic total gastrectomy using endoscopic linear stapler: early experiences at one institute. J Laparoendosc Adv Surg Tech A, 2012. 22(9): p. 889-97.
90. Jeong, J.H., et al., Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer. Cancer Chemother Pharmacol, 2012. 70(4): p. 523-9.
91. Lee, J.H., et al., Clinical impact of EUS-guided Trucut biopsy results on decision making for patients with gastric subepithelial tumors ≥ 2 cm in diameter. Gastrointest Endosc, 2011. 74(5): p. 1010-8.
92. Kim, M.G., et al., Influence of obesity on early surgical outcomes of laparoscopic-assisted gastrectomy in gastric cancer. Surg Laparosc Endosc Percutan Tech, 2011. 21(3): p. 151-4.
93. Kim, M.G., et al., A totally laparoscopic distal gastrectomy can be an effective way of performing laparoscopic gastrectomy in obese patients (body mass index≥30). World J Surg, 2011. 35(6): p. 1327-32.
94. Kim, M.G., et al., The effects of laparoscopic assisted total gastrectomy on surgical outcomes in the treatment of gastric cancer. J Korean Surg Soc, 2011. 80(4): p. 245-50.
95. Kim, M.G., et al., A totally laparoscopic distal gastrectomy with gastroduodenostomy (TLDG) for improvement of the early surgical outcomes in high BMI patients. Surg Endosc, 2011. 25(4): p. 1076-82.
96. Kim, K.C., et al., Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays. Ann Surg Oncol, 2011. 18(10): p. 2833-40.
97. Kim, B.S., et al., Comparison of early outcomes of intracorporeal and extracorporeal gastroduodenostomy after laparoscopic distal gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A, 2011. 21(5): p. 387-91.
98. Kang, Y.K., et al., Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol, 2011. 67(6): p. 1435-43.
99. Chung, J.W., et al., Extended indication of endoscopic resection for mucosal early gastric cancer: analysis of a single center experience. J Gastroenterol Hepatol, 2011. 26(5): p. 884-7.
100. Choi, K.S., et al., EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointest Endosc, 2011. 73(5): p. 942-8.
101. Yoon, S.N., et al., In vitro chemosensitivity of gastric adenocarcinomas to histone deacetylase inhibitors, compared to established drugs. Hepatogastroenterology, 2010. 57(99-100): p. 657-62.
102. Sym, S.J., et al., Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. Cancer Chemother Pharmacol, 2010. 66(2): p. 373-80.
103. Sym, S.J., et al., Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. Ann Surg Oncol, 2010. 17(4): p. 1024-32.
104. Kim, J.H., et al., Palliative treatment of malignant gastric outlet obstructions with a large-diameter metallic stent: prospective preliminary study. J Vasc Interv Radiol, 2010. 21(7): p. 1125-8.
105. Kim, B.S., et al., Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. Am J Surg, 2010. 200(3): p. 328-33.
106. Sym, S.J., et al., Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs). J Surg Oncol, 2008. 98(1): p. 27-33.
107. Sym, S.J., et al., A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer. Cancer Chemother Pharmacol, 2008. 63(1): p. 1-8.
108. Park, Y.S., et al., The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol, 2008. 15(7): p. 1968-76.
109. Lee, J.L., et al., A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy. Cancer Chemother Pharmacol, 2008. 61(4): p. 631-7.
110. Kim, J.H., et al., Early symptomatic strictures after gastric surgery: palliation with balloon dilation and stent placement. J Vasc Interv Radiol, 2008. 19(4): p. 565-70.
111. Chang, H.M., et al., PDGFRalpha gene mutation and protein expression in gastrointestinal stromal tumors. Oncology, 2008. 74(1-2): p. 88-95.
112. Yang, Z.Q., et al., Covered stent placement in patients with recurrent cancer after a Billroth I reconstruction. J Vasc Interv Radiol, 2007. 18(12): p. 1533-7.
113. Song, H.Y., et al., Metallic stent placement in patients with recurrent cancer after gastrojejunostomy. J Vasc Interv Radiol, 2007. 18(12): p. 1538-46.
114. Kim, J.H., et al., Stent collapse as a delayed complication of placement of a covered gastroduodenal stent. AJR Am J Roentgenol, 2007. 188(6): p. 1495-9.
115. Kim, J.H., et al., Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc, 2007. 66(2): p. 256-64.
116. Oh, J.S., et al., Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three cases. Cancer Res Treat, 2006. 38(3): p. 178-83.
117. Lee, J.L., et al., Efficacy and safety study of docetaxel as salvage chemotherapy in metastatic gastric cancer failing fluoropyrimidine and platinum combination chemotherapy. Cancer Res Treat, 2005. 37(4): p. 201-7.
118. Kim, H.C., et al., Aberrant CpG island methylation in early-onset sporadic gastric carcinoma. J Cancer Res Clin Oncol, 2005. 131(11): p. 733-40.
119. Song, H.Y., et al., A dual expandable nitinol stent: experience in 102 patients with malignant gastroduodenal strictures. J Vasc Interv Radiol, 2004. 15(12): p. 1443-9.
120. Kim, T.W., et al., Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res, 2004. 10(9): p. 3076-81.